Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Vaccines|August 28, 2021
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1Khalid A Alluhaybi, Rahaf H Alharbi, Rowa Y Alhabbab, et al.Virology Journal|January 4, 2025
Full-length genome reveals genetic diversity and extensive recombination patterns of Saudi GI-1 and GI-23 genotypes of infectious bronchitis virusAli N Alhafufi, Samy Kasem, Fahad N Almajhdi, et al.Viruses|August 10, 2021
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi ArabiaRowa Y Alhabbab, Ahdab Alsaieedi, Abdullah Algaissi, et al.Antibody Therapeutics|February 19, 2024
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaksMohamed A Alfaleh, Reem M Alsulaiman, Sarah A Almahboub, et al.Journal of Medical Virology|June 23, 2026
Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic CoronavirusesAssala Helal, Najwa D Aljehani, Aishah Ghazwani, et al.Transboundary and Emerging Diseases|April 30, 2025
A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS-CoV-2 Variants of ConcernRwaa H Abdulal, Muhammad Yasir Khan, Najwa D Aljehani, et al.Vaccine|November 13, 2025
Intranasal CD40-targeted recombinant MERS-CoV S1 protein is superior to intramuscular immunization in eliciting systemic and mucosal immune responses in miceMuhammad Yasir Khan, Najwa D Aljehani, Rwaa H Abdulal, et al.Mbio|December 4, 2024
Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animalsNajwa D Aljehani, Levi Tamming, Muhammad Yasir Khan, et al.Pageof 1